with Allosteric Enzymes
in the Presence of an Inhibitor
When the end product (inhibitor)
of a pathway combines with the allosteric site of the enzyme, this alters the active site of the
enzyme so it can no longer bind to the starting substrate of the
pathway. This blocks production of the end product.